These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 17885562

  • 1. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
    Mallion JM, Heagerty A, Laeis P.
    J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
    Chrysant SG, Weber MA, Wang AC, Hinman DJ.
    Am J Hypertens; 2004 Mar; 17(3):252-9. PubMed ID: 15001200
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM, Omboni S, Barton J, Van Mieghem W, Narkiewicz K, Panzer PK, Puig JG, Stefanadis C, Zweiker R, Study Group.
    Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
    Chrysant SG, Chavanu KJ, Xu J.
    Am J Cardiovasc Drugs; 2009 Apr; 9(4):241-51. PubMed ID: 19655819
    [Abstract] [Full Text] [Related]

  • 5. Effect of an olmesartan medoxomil-based treatment algorithm on systolic blood pressure in patients with stage 1 or 2 hypertension: a randomized, double-blind, placebo-controlled study.
    Kereiakes DJ, Maa JF, Shojaee A, Dubiel R.
    Am J Cardiovasc Drugs; 2010 Apr; 10(4):239-46. PubMed ID: 20653330
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
    Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.
    Clin Drug Investig; 2007 Apr; 27(8):545-58. PubMed ID: 17638395
    [Abstract] [Full Text] [Related]

  • 7. Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials.
    Heagerty AM, Mallion JM.
    Drugs Aging; 2009 Apr; 26(1):61-76. PubMed ID: 19102515
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
    Fogari R, Taddei S, Holm-Bentzen M, Baszak J, Melani L, Schumacher K.
    Clin Drug Investig; 2010 Apr; 30(9):581-97. PubMed ID: 20593911
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA.
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ, Neutel JM, Punzi HA, Xu J, Lipka LJ, Dubiel R.
    Am J Cardiovasc Drugs; 2007 Feb; 7(5):361-72. PubMed ID: 17953475
    [Abstract] [Full Text] [Related]

  • 11. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K, Ogihara T, Saruta T, Kuramoto K, REZALT Study Group.
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
    Chrysant SG, Marbury TC, Robinson TD.
    J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
    [Abstract] [Full Text] [Related]

  • 13. Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension.
    Greathouse M.
    Vasc Health Risk Manag; 2006 Jun; 2(4):401-9. PubMed ID: 17323594
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
    Oparil S, Chrysant SG, Melino M, Lee J, Karki S, Heyrman R.
    J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
    [Abstract] [Full Text] [Related]

  • 15. Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension.
    Rosenbaum D, Girerd X.
    Curr Med Res Opin; 2012 Feb; 28(2):179-86. PubMed ID: 22114906
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.
    Volpe M, Miele C, Haag U.
    Clin Drug Investig; 2009 Feb; 29(6):381-91. PubMed ID: 19432498
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J, Shojaee A, Maa JF.
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.
    Malacco E, Omboni S, Mallion JM, Volpe M, ESPORT Study Group.
    High Blood Press Cardiovasc Prev; 2012 Dec; 19(4):213-22. PubMed ID: 23430666
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Volpe M, Brommer P, Haag U, Miele C.
    Clin Drug Investig; 2009 Dec; 29(1):11-25. PubMed ID: 19067471
    [Abstract] [Full Text] [Related]

  • 20. Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study.
    Barrios V, Escobar C, Calderon A, Böhm M.
    Vasc Health Risk Manag; 2009 Dec; 5():723-9. PubMed ID: 19756164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.